Skip to main content

Blood Plasma Derivatives Market is Growing at a Promising CAGR of 10.1% During Forecast to 2025


Blood Plasma Derivatives Market Research Report: Information by Type [Factor VIII Concentrate, Factor IX Concentrate, Albumin, Immune Globulins, Anti-Thrombin III Concentrate, and Fresh Frozen Plasma (FFP)], Application (HIV, Hemophilia A, Hemophilia B, Hepatitis B, Hepatitis C, Bleeding Disorders, Hypogammaglobulinemia, Immunodeficiency Diseases, and Others), End User (Hospitals & Clinics, Blood Transfusion Centers, Diagnostic Centers, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2025
Market Analysis:
Various factors are propelling the blood plasma derivatives market growth. These factors, as per the new MRFR report, include growing demand for plasma derivative-based therapies, increasing incidence of hemophilia, increasing funding for R&D activities, advancements in technology, and growing approval from regulatory bodies. Additional factors propelling market growth include increasing prevalence of life-threatening diseases, including hepatitis and HIV, and various non-government and government organizations conducting and promoting blood donation camps.
The global Blood Plasma Derivatives Market Insights is predicted to touch USD 33,590 million at a 10.1% CAGR over the forecast period (2019-2025), states the new Market Research Future (MRFR) report. Plasma is a fluid portion of the blood which contains protein and blood cells that are responsible for blood clotting. The plasma derivative is obtained from definite plasma proteins through fractionation. Then the derivatives are heat-treated or solvent detergent-treated for killing viruses. Blood plasma helps in maintaining the blood pressure and assist in exchanging of essential minerals such as potassium and sodium for maintaining the body’s pH balance.  


The rise in global geriatric population also fuels the growth of the blood plasma derivatives market. The elderly population is generally at more risk of acquiring life-threatening diseases which consequently necessitates treatment and further intensifies the growth of the market.
Other driving factors include raising awareness regarding blood and plasma donation and advancement in the preservation techniques of blood plasma. Also, an outlay of substantial amounts on research & development activities and expanding range of clinical applications of blood plasma derivatives are expected to be a tailwind for the growth of the global blood plasma derivatives market.
Key Players:
·         Bain Capital
·         Biotest AG
·         Octapharma AG
·         CSL Limited
·         Baxter International Inc
·         Fusion Healthcare
·         SK Plasma
·         Grifols
Market Segmentation: 

·         The MRFR report provides an all-inclusive segmental analysis of the blood plasma derivatives market report on the basis of type, end user, and application. 
·         Based on type, the blood plasma derivatives market is segmented into fresh frozen plasma (FFP), intravenous immunoglobulin (IVIG), anti-thrombin, albumin, and others.

·         Based on application, the blood plasma derivatives market is segmented into Thrombocytosis, Hepatitis C, Hepatitis B, HIV, Hemophilia B, Hemophilia A, and others. Others include Von Willebrand disease. 

·         Based on end users, the blood plasma derivatives market is segmented into blood transfusion centers, diagnostic centers, hospitals, and others.

Regional Analysis:
By region, the blood plasma derivatives market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, North America, and the Middle East and Africa. Of these, North America will spearhead the blood plasma derivatives market over the forecast period. It is predicted to grow at a 4.25% CAGR. This region is the largest market for needle and syringe. Awareness about the usage of plasma derivatives for patients with infectious diseases is boosting the market growth in the region. 
The blood plasma derivatives market in Europe is predicted to have the second-largest share in the market over the forecast period. It is predicted to grow at a 3.8% CAGR. Factors aiding growth in the region include extensive research on safe blood transfusion in research laboratories and healthcare organizations. 
The blood plasma derivatives market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is chiefly due to the burgeoning demand for plasma derivatives for inactivation of HIV. India is the key contributor in this region. 
The blood plasma derivatives market in the Middle East and Africa is predicted to have a steady growth over the forecast period. 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.




Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...